Effects of SC-52458, a New Nonpeptide Angiotensin II Receptor Antagonist, on Increase in Cytoplasmic Ca 2+ Concentrations and Contraction Induced by Angiotensin II and K + -Depolarization in Guinea-Pig Taenia Coli

By Usune S.   Furukawa T.  

General Pharmacology, Vol. 27, Iss. 7, 1996-10 ,pp. : 1179-1185

Elsevier

Access to resources Recommend Favorite

Omapatrilat Limits Infarct Size and Lowers the Threshold for Induction of Myocardial Preconditioning Through a Bradykinin Receptor-Mediated Mechanism

By Ebrahim Z.   Baxter G.F.   Yellon D.M.  

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 2, 2004-03 ,pp. : 127-134

Springer Publishing Company

Access to resources Recommend Favorite

Synthesis and angiotensin II receptor antagonist activity of C-linked pyrimidine derivatives

By Nicolai E.   Cure G.   Goyard J.   Kirchner M.   Teulon J.   Versigny A.   Cazes M.   Virone-Oddos A.   Caussade F.   Cloarec A.  

European Journal of Medicinal Chemistry, Vol. 30, Iss. 5, 1995-01 ,pp. : 365-375

Elsevier

Access to resources Recommend Favorite

Pharmacological profile of ME3221, a novel angiotensin II receptor antagonist

By Nagura J.   Yasuda S.   Fujishima K.   Yamamoto M.   Hui C.   Kawano K.-i.   Katano K.   Ogino H.   Hachisu M.   Konno F.  

European Journal of Pharmacology, Vol. 274, Iss. 1, 1995-02 ,pp. : 201-211

Elsevier

Access to resources Recommend Favorite

Pharmacology of CS-866, a novel nonpeptide angiotensin II receptor antagonist

By Mizuno M.   Sada T.   Ikeda M.   Fukuda N.   Miyamoto M.   Yanagisawa H.   Koike H.  

European Journal of Pharmacology, Vol. 285, Iss. 2, 1995-10 ,pp. : 181-188

Elsevier

Access to resources Recommend Favorite